Battle of the Biotech Bands - A Great Time for a Great Cause - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Battle of the Biotech Bands - A Great Time for a Great Cause


Battle of the Biotech Bands - A Great Time for a Great Cause

PR Newswire

WELLESLEY, Mass., June 12, 2014 /PRNewswire/ -- BioBridges, a leading clinical contract consulting company, is so proud to have joined the sponsorship of the second annual Battle of the Biotech Bands. BoBB is a fun, community-driven, networking event with fundraising efforts supporting the charitable foundation affiliated with each biotech band.

The event brought together three bands: BAD IDEA from Merrimack Pharmaceuticals, AURAL GAVAGE from Momenta Pharmaceuticals and MOLECULAR GROOVE from PerkinElmer. With 700 in attendance and over $60,000 raised, the top honor went to BAD IDEA awarding $30,000 to their charity Dream Day of Cape Cod. AURAL GAVAGE and MOLECULAR GROOVE each earned $15K for their respective charities: the Jolane Solomon Research Fund at Boston College and The American Cancer Society.

"As a long-term client, we were so proud to be a sponsor and support Merrimack Pharmaceuticals," said Jason Falchuk, managing partner of BioBridges. "It was truly an amazing evening of celebration with a purpose. This event serves as another humble reminder of how fortunate BioBridges is to be a part of the life sciences community working alongside such talented people who are committed to bringing life changing therapies to the market and supporting great causes."

"Merrimack Pharmaceuticals' band 'Bad Idea', winners in the 2nd Annual Battle of the Biotech Bands, thanks BioBridges for their generous support! We at Merrimack are thrilled to have participated in this charity event, and grateful to the BioBridges team for their support and generosity," said VP Quality at Merrimack Pharmaceuticals (and band member, "Bad Idea"), Bob Corcoran. "BioBridges has been a trusted and reliable partner providing top-notch consulting services to Merrimack for many years. We value our ongoing collaboration as we bring our cancer therapies to patients."

The event was held May 16, 2014 at the Royale Night Club, Boston and provided an amazing evening for all involved. "We are so excited to be able to be a part of such a fine event. BAD IDEA was anything but a BAD IDEA," said Cindy Steinberg, managing partner of BioBridges.

For more information on Battle of the Biotech Bands, please click here (http://www.battleofthebiotechbands.com).

About BioBridges
BioBridges provides critical contract consulting expertise and hands-on resources to help growing pharmaceutical, biotechnology and medical device companies successfully achieve their clinical and business goals.

SOURCE BioBridges

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here